369 related articles for article (PubMed ID: 21357908)
1. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
Clase CM; Gao P; Tobe SW; McQueen MJ; Grosshennig A; Teo KK; Yusuf S; Mann JF;
Ann Intern Med; 2011 Mar; 154(5):310-8. PubMed ID: 21357908
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
Tobe SW; Clase CM; Gao P; McQueen M; Grosshennig A; Wang X; Teo KK; Yusuf S; Mann JF;
Circulation; 2011 Mar; 123(10):1098-107. PubMed ID: 21357827
[TBL] [Abstract][Full Text] [Related]
3. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
4. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
[TBL] [Abstract][Full Text] [Related]
5. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
Matsushita K; Coresh J; Sang Y; Chalmers J; Fox C; Guallar E; Jafar T; Jassal SK; Landman GW; Muntner P; Roderick P; Sairenchi T; Schöttker B; Shankar A; Shlipak M; Tonelli M; Townend J; van Zuilen A; Yamagishi K; Yamashita K; Gansevoort R; Sarnak M; Warnock DG; Woodward M; Ärnlöv J;
Lancet Diabetes Endocrinol; 2015 Jul; 3(7):514-25. PubMed ID: 26028594
[TBL] [Abstract][Full Text] [Related]
6. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Mann JF; Schmieder RE; McQueen M; Dyal L; Schumacher H; Pogue J; Wang X; Maggioni A; Budaj A; Chaithiraphan S; Dickstein K; Keltai M; Metsärinne K; Oto A; Parkhomenko A; Piegas LS; Svendsen TL; Teo KK; Yusuf S;
Lancet; 2008 Aug; 372(9638):547-53. PubMed ID: 18707986
[TBL] [Abstract][Full Text] [Related]
7. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
; Matsushita K; van der Velde M; Astor BC; Woodward M; Levey AS; de Jong PE; Coresh J; Gansevoort RT
Lancet; 2010 Jun; 375(9731):2073-81. PubMed ID: 20483451
[TBL] [Abstract][Full Text] [Related]
8. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Emrich I; Mancia G; Redon J; Schmieder RE; Sliwa K; Lehrke M; Marx N; Weber MA; Williams B; Yusuf S; Mann JFE
J Hypertens; 2021 Apr; 39(4):766-774. PubMed ID: 33560052
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
[TBL] [Abstract][Full Text] [Related]
10. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey A; de Jong P; Gansevoort RT; ; van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey AS; de Jong PE; Gansevoort RT; Levey A; El-Nahas M; Eckardt KU; Kasiske BL; Ninomiya T; Chalmers J; Macmahon S; Tonelli M; Hemmelgarn B; Sacks F; Curhan G; Collins AJ; Li S; Chen SC; Hawaii Cohort KP; Lee BJ; Ishani A; Neaton J; Svendsen K; Mann JF; Yusuf S; Teo KK; Gao P; Nelson RG; Knowler WC; Bilo HJ; Joosten H; Kleefstra N; Groenier KH; Auguste P; Veldhuis K; Wang Y; Camarata L; Thomas B; Manley T
Kidney Int; 2011 Jun; 79(12):1341-52. PubMed ID: 21307840
[TBL] [Abstract][Full Text] [Related]
11. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B;
Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068
[TBL] [Abstract][Full Text] [Related]
12. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.
Nitsch D; Grams M; Sang Y; Black C; Cirillo M; Djurdjev O; Iseki K; Jassal SK; Kimm H; Kronenberg F; Oien CM; Levey AS; Levin A; Woodward M; Hemmelgarn BR;
BMJ; 2013 Jan; 346():f324. PubMed ID: 23360717
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease.
Vlek AL; van der Graaf Y; Spiering W; Algra A; Visseren FL;
J Intern Med; 2008 Oct; 264(4):351-60. PubMed ID: 18522685
[TBL] [Abstract][Full Text] [Related]
14. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
Smink PA; Lambers Heerspink HJ; Gansevoort RT; de Jong PE; Hillege HL; Bakker SJ; de Zeeuw D
Am J Kidney Dis; 2012 Nov; 60(5):804-11. PubMed ID: 22835901
[TBL] [Abstract][Full Text] [Related]
15. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
[TBL] [Abstract][Full Text] [Related]
16. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
Heerspink HJ; Persson F; Brenner BM; Chaturvedi N; Brunel P; McMurray JJ; Desai AS; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):309-17. PubMed ID: 26774608
[TBL] [Abstract][Full Text] [Related]
17. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
Fung CS; Wan EY; Chan AK; Lam CL
BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
[TBL] [Abstract][Full Text] [Related]
18. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.
Hallan S; Astor B; Romundstad S; Aasarød K; Kvenild K; Coresh J
Arch Intern Med; 2007 Dec; 167(22):2490-6. PubMed ID: 18071172
[TBL] [Abstract][Full Text] [Related]
19. eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.
Bansal N; Zelnick LR; Alonso A; Benjamin EJ; de Boer IH; Deo R; Katz R; Kestenbaum B; Mathew J; Robinson-Cohen C; Sarnak MJ; Shlipak MG; Sotoodehnia N; Young B; Heckbert SR
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1386-1398. PubMed ID: 28798221
[TBL] [Abstract][Full Text] [Related]
20. Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men.
Carlsson AC; Larsson A; Helmersson-Karlqvist J; Lind L; Ingelsson E; Larsson TE; Bottai M; Sundström J; Ärnlöv J
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1393-401. PubMed ID: 24923577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
